Dopaminergic involvement in attention a novel animal model
dc.contributor.author | Katz, Richard J. | en_US |
dc.contributor.author | Schmaltz, Kristine | en_US |
dc.date.accessioned | 2006-04-07T18:13:13Z | |
dc.date.available | 2006-04-07T18:13:13Z | |
dc.date.issued | 1981 | en_US |
dc.identifier.citation | Katz, R. J., Schmaltz, K. (1981)."Dopaminergic involvement in attention a novel animal model." Progress in Neuro-Psychopharmacology 4(6): 585-590. <http://hdl.handle.net/2027.42/24570> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B73FH-4CVPW47-M/2/6443a67879dddfdd138c5ccc38efa9cf | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/24570 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=7220672&dopt=citation | en_US |
dc.description.abstract | 1. 1. Adult male outbred albino mice were acutely injected with either of two dopamine (DA) agonists; Apomorphine, a receptor agonist, or Amantadine, a DA releasing agent.2. 2. Both drugs produced dose-related alterations in initial Y-maze behavior, consisting of significantly increased proportions of 2-arm entries.3. 3. This behavior has previously been shown to reflect an abnormal attentional process.4. 4. Thus DA activation may cause sensory perseveration.5. 5. The implications of this finding for DA theories of psychopathology is discussed. | en_US |
dc.format.extent | 332772 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Dopaminergic involvement in attention a novel animal model | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Psychiatry | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbsecondlevel | Chemistry | en_US |
dc.subject.hlbsecondlevel | Biological Chemistry | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Mental Health Research Institute, Department of Psychiatry University of Michigan Medical Center, Ann, Arbor, Michigan, USA | en_US |
dc.contributor.affiliationum | Mental Health Research Institute, Department of Psychiatry University of Michigan Medical Center, Ann, Arbor, Michigan, USA | en_US |
dc.identifier.pmid | 7220672 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/24570/1/0000852.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0364-7722(81)90099-0 | en_US |
dc.identifier.source | Progress in Neuro-Psychopharmacology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.